Viewing Study NCT04862650


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-28 @ 1:53 PM
Study NCT ID: NCT04862650
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-10
First Post: 2021-03-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor: Marcelo Bonomi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module